Multispecific Deimmunized Cd3-Binders

Patent No. EP2292664 (titled "Multispecific Deimmunized Cd3-Binders") was filed by Amgen Research Munich on Oct 15, 2004. The application was issued on Nov 23, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JANSSEN BIOTECHAug 23, 2017GOODFELLOW

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2292664

AMGEN RESEARCH MUNICH
Application Number
EP10177720A
Filing Date
Oct 15, 2004
Status
Revoked
Jan 11, 2019
Publication Date
Nov 23, 2016